Luciana Godoy Viana
Papers
3
Total Citations
155
H-Index
3
About
Luciana Godoy Viana is a leading researcher in mass spectrometry-based clinical proteomics, with a primary focus on developing rapid, high-throughput diagnostic tools for infectious diseases. Her most impactful work centers on the detection of SARS-CoV-2, where she pioneered a targeted proteomics assay that identifies viral nucleoprotein peptides directly from clinical samples. This approach, detailed in her highly cited 2020 paper (126 citations), offers a fast, low-cost alternative to traditional PCR testing, enabling large-scale population screening during the pandemic. Viana’s contributions extend to refining tandem mass spectrometry methods for peptide detection, achieving both speed and affordability without compromising sensitivity. Her work has been instrumental in bridging the gap between advanced proteomics and real-world public health needs, demonstrating how mass spectrometry can be deployed for emergency outbreak response. By establishing robust, scalable workflows for viral detection, Viana has not only advanced the field of clinical proteomics but also provided critical tools for pandemic control. Her research continues to inspire innovations in diagnostic technology, making her a key figure in the application of mass spectrometry to global health challenges.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3